Please assess the completion status of the following clinical trial:

Trial Title: Employment-Based Depot Naltrexone Clinical Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Individuals were eligible if they:~* met the Diagnostic and Statistical Manual of Mental Disorders, 4th. Edition (DSM-IV) criteria for opioid dependence,~* reported using heroin on at least 21 of the last 30 days while in community,~* were unemployed,~* were aged 18-65 years,~* were medically approved for naltrexone~* lived in or near Baltimore, MD.~Individuals were excluded if they~* had current DSM-IV major Axis I disorders,~* had current suicidal or homicidal ideation,~* expressed interest in methadone treatment,~* were required to use opioids for medical purposes,~* earned more than $200 in taxable income over the previous 30 days,~* had physical limitations that would prevent them from using a keyboard,~* were pregnant or breastfeeding,~* had serum aminotransferase levels more than three times over normal.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- No Intervention (Type: NO_INTERVENTION): Participants were offered depot naltrexone injections and were not required to take scheduled injections to work.
- Employment-based reinforcement (Type: EXPERIMENTAL): Participants were offered depot naltrexone injections and were required to take scheduled injections to work.

Based on this trial design, predict the completion outcome and termination type (if applicable).